Guardian Pharmacy Services, Inc. Financing Cash Flow
Guardian Pharmacy Services, Inc. (GRDN) reported Financing Cash Flow of -$2.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$805.00K.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.04M.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$758.00K.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.53M, a 103.41% decline year-over-year.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$7.07M.
- Guardian Pharmacy Services, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$23.64M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$805.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.84M 10-Q · filed 2026-08-06 | -$3.60M derived: sum of 3 quarters · filed 2026-08-06 | -$5.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.04M 10-Q · filed 2026-05-06 | -$2.80M derived: sum of 2 quarters · filed 2026-05-06 | -$4.33M derived: sum of 3 quarters · filed 2026-05-06 | -$6.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$2.29M derived: sum of 2 quarters · filed 2026-03-11 | -$4.41M derived: sum of 3 quarters · filed 2026-08-06 | -$7.07M 10-K · filed 2026-03-11 |
| 2025-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.65M derived: sum of 2 quarters · filed 2026-08-06 | -$6.31M 10-Q · filed 2025-11-10 | -$54.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.78M 10-Q · filed 2026-08-06 | -$53.05M derived: sum of 3 quarters · filed 2026-08-06 | -$8.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.67M 10-Q · filed 2026-05-06 | -$50.94M derived: sum of 2 quarters · filed 2026-05-06 | -$6.01M derived: sum of 3 quarters · filed 2026-05-06 | -$20.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$48.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$3.35M derived: sum of 2 quarters · filed 2026-03-11 | -$18.01M derived: sum of 3 quarters · filed 2026-03-11 | -$23.64M 10-K · filed 2026-03-11 |
| 2024-09-30 | $44.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $30.26M derived: sum of 2 quarters · filed 2025-11-10 | $24.63M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$14.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$20.30M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$5.63M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | -$43.96M 10-Q · filed 2024-11-12 |